Gene · 6300
Papers1,954
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,954
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unraveling the signaling pathways of phytohormones underlying salt tolerance in Elymus sibiricus: A transcriptomic and metabolomic approach. | Genomics | 2024 | 38944355 | PubTator, text mining | PubMed |
| Long non-coding intergenic RNA, LINC00273 induces cancer metastasis and stemness via miRNA sponging in triple negative breast cancer. | Int J Biol Macromol | 2024 | 38857735 | PubTator, text mining | PubMed |
| A retrospective analysis of the clinicopathological features and prognostic value of MAPK12 protein expression in diffuse large B-cell lymphoma. | Clin Transl Oncol | 2024 | 38773060 | PubTator, text mining | PubMed |
| Phosphorylation of cell cycle and apoptosis regulatory protein-1 by stress activated protein kinase P38γ is a novel mechanism of apoptosis signaling by genotoxic chemotherapy. | Front Oncol | 2024 | 38756656 | PubTator, text mining | PubMed |
| GABA does not regulate stomatal CO2 signalling in Arabidopsis. | J Exp Bot | 2024 | 38628155 | PubTator, text mining | PubMed |
| Pirfenidone ameliorates alcohol-induced promotion of breast cancer in mice. | Front Oncol | 2024 | 38590657 | PubTator, text mining | PubMed |
| DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC. | Mol Oncol | 2024 | 38572507 | PubTator, text mining | PubMed |
| Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11. | Eur J Pharmacol | 2024 | 38561103 | PubTator, text mining | PubMed |
| CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder. | Front Pharmacol | 2024 | 38549671 | PubTator, text mining | PubMed |
| Phosphorylation of human glioma-associated oncogene 1 on Ser937 regulates Sonic Hedgehog signaling in medulloblastoma. | Nat Commun | 2024 | 38307877 | PubTator, text mining | PubMed |
| MuSCs and IPCs: roles in skeletal muscle homeostasis, aging and injury. | Cell Mol Life Sci | 2024 | 38289345 | PubTator, text mining | PubMed |
| Prone Positioning and Molecular Biomarkers in COVID and Non-COVID ARDS: A Narrative Review. | J Clin Med | 2024 | 38256451 | PubTator, text mining | PubMed |
| Temporal Quantitative Proteomic and Phosphoproteomic Profiling of SH-SY5Y and IMR-32 Neuroblastoma Cells during All-Trans-Retinoic Acid-Induced Neuronal Differentiation. | Int J Mol Sci | 2024 | 38256121 | PubTator, text mining | PubMed |
| p38 Molecular Targeting for Next-Generation Multiple Myeloma Therapy. | Cancers (Basel) | 2024 | 38254747 | PubTator, text mining | PubMed |
| Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review. | Cancers (Basel) | 2024 | 38254735 | PubTator, text mining | PubMed |
| Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control. | Cell Death Dis | 2024 | 38253602 | PubTator, text mining | PubMed |
| Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery. | J Exp Clin Cancer Res | 2024 | 38245798 | PubTator, text mining | PubMed |
| Alzheimer's disease, a metabolic disorder: Clinical advances and basic model studies (Review). | Exp Ther Med | 2024 | 38234618 | PubTator, text mining | PubMed |
| G-quadruplex structural dynamics at MAPK12 promoter dictates transcriptional switch to determine stemness in breast cancer. | Cell Mol Life Sci | 2024 | 38214819 | PubTator, text mining | PubMed |
| Natural products targeting the MAPK-signaling pathway in cancer: overview. | J Cancer Res Clin Oncol | 2024 | 38193944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6300/papers?page=4